Over the last five years, the industry has traded as high as 20.80X, as low as 12.92X and at a median of 15.13X, as the chart below shows ... s blockbuster drug, Humira, are declining due to ...

The drug and biotech sector has recovered over the past couple of months, following a slow start to the year, primarily due ...

Dosage for Humira (adalimumab) may vary based on the condition it’s being used to treat. Also, your doctor may adjust your dosage over the course of your treatment. Be sure to take the Humira ...

If you're looking for safety within the healthcare sector, a top name to consider right now is Abbott Laboratories. For ...

Yet, their place and cost remain fairly misunderstood. For over a decade, Humira has been the highest-grossing drug in the world, bringing in some $21 billion for manufacturer AbbVie in 2021.

The drug and biotech sector has recovered over the past couple of months, following a slow start to the year, primarily due to the better-than-expected fourth-quarter performance of large ...

Alvotech’s revenues grew by 400% year-over-year to $492 million. The company launched biosimilars for HUMIRA and STELARA in multiple markets. EPS fell short of expectations, with a reported loss ...

Humira’s success is down to its incredible versatility – an anti-TNF drug, it is approved in a range of inflammatory diseases, including rheumatoid arthritis, plaque psoriasis and Crohn’s ...

Alvotech’s revenues grew by 400% year-over-year to $492 million. The company launched biosimilars for HUMIRA and STELARA in multiple markets. EPS fell short of expectations, with a reported loss of $0 ...

Schedule 1 is the latest breakout hit on Steam, an open-world drug empire simulator that’s quickly climbed the charts thanks to its gritty gameplay and tongue-in-cheek humor. Just days after its ...

The drug and biotech sector has recovered over the past couple of months, following a slow start to the year, primarily due to the better-than-expected fourth-quarter performance of large drugmakers ...